drugset / Trial / NCT07456423

Adenosine vs. Diltiazem

NCT07456423

Phase 4 Completed 140 enrolled Haseki Training and Research Hospital
RandomizedCrossoverSingle-blindTreatment

Summary

In this Emergency Department (ED)-based study, the investigators evaluated a standardized modified Valsalva maneuver (MVM) as first-line therapy and compared intravenous (IV) adenosine with IV diltiazem among patients with persistent atrioventricular nodal re-entrant tachycardia (AVNRT)-consistent supraventricular tachycardia (SVT) after MVM, focusing on successful conversion to sinus rhythm. The investigators also assessed drug-related adverse events and clinically relevant treatment-course measures.

Timeline

Start
2024-07-01
Primary completion
2025-06-30
Completion
2025-08-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adenosine Small molecule 6 mg Intravenous
Comparator Diltiazem Small molecule 0.25 mg/kg Intravenous